Basics NeoGenomics, Inc. NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee. IPO Date: December 10, 2012 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $965.21M Activated in VL: True Average Daily Range Avg Daily Range: $0.34 | 2.25% Avg Daily Range (30 D): $0.28 | 3.27% Avg Daily Range (90 D): $0.33 | 3.36% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): 2.13M Avg Daily Volume (90 D): 1.48M Trade Size Avg Trade Size (Sh.): 93 Avg Trade Size (Sh.) (30 D): 118 Avg Trade Size (Sh.) (90 D): 95 Institutional Trades Total Inst.Trades: 3,554 Avg Inst. Trade: $2.16M Avg Inst. Trade (30 D): $2.06M Avg Inst. Trade (90 D): $2.01M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $1.77M Avg Closing Trade (90 D): $2.02M Avg Closing Volume: 140.34K         News May 6, 2025 @ 4:20 PM It's Not Too Late to Jump on These Under-the-Radar... Source: Marketbeat.Com Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com Feb 17, 2025 @ 10:28 PM Not Just a DEX: How Pineapple’s Mystery Mar... Source: N/A Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Nov 22, 2024 @ 7:27 AM Gene Panel Market to Surpass USD 11.75 Billion by ... Source: Skyquest Financials   TTM Q1 2025 Q4 2024 Basic EPS Diluted EPS Revenue $ 672.36M $ 168.04M $ 172M Gross Profit $ 297.88M $ 73.25M $ 77.26M Net Income / Loss $ -77.59M $ -25.92M $ -15.32M Operating Income / Loss $ -89.36M $ -27.83M $ -18.4M Cost of Revenue $ 374.48M $ 94.79M $ 94.74M Net Cash Flow $ 14.28M $ -20.82M $ 5.02M PE Ratio     Splits Apr 16, 2003:   1:100 Nov 17, 2000:   4:1